Journal of Pharmacology and Experimental Therapeutics: 250 (3)

September 01, 1989; Volume 250,Issue 3

You have access
A stereoselective central hypotensive action of atenolol.
A A Pearson, T E Gaffney, T Walle and P J Privitera

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 759-763;
You have access
Renal periarterial nerve stimulation-induced vasoconstriction at low frequencies is primarily due to release of a purinergic transmitter in the rat.
D D Schwartz and K U Malik

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 764-771;
You have access
In vitro evidence that urine composition affects the fraction of active furosemide in the nephrotic syndrome.
J R Voelker, D M Jameson and D C Brater

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 772-778;
You have access
Discriminative stimulus properties of histamine H1-antagonists in animals trained to discriminate d-amphetamine or pentobarbital.
S M Evans and C E Johanson

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 779-787;
You have access
Acute and chronic effects of corticotropin-releasing factor on schedule-controlled responding and neurochemistry of pigeons.
J E Barrett, L Zhang, S T Ahlers and F H Wojnicki

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 788-794;
You have access
Inhibition of bradykinin-induced increases of cytosolic Ca++ by a novel amiloride analog.
D W Coyne, M Mordhorst, E J Cragoe and A R Morrison

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 795-799;
You have access
Behavioral differentiation of the stimulus properties of a dopaminergic D1 agonist from a D2 agonist.
D A Cory-Slechta, D V Widzowski and M C Newland

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 800-808;
You have access
Behavioral studies with anxiolytic drugs. VI. Effects on punished responding of drugs interacting with serotonin receptor subtypes.
S Gleeson, S T Ahlers, R S Mansbach, J M Foust and J E Barrett

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 809-817;
You have access
Cocaine selectively increases striatonigral dynorphin levels by a dopaminergic mechanism.
S P Sivam

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 818-824;
You have access
Role of mu and kappa opioid receptors in conditional fear-induced analgesia: the antagonistic actions of nor-binaltorphimine and the cyclic somatostatin octapeptide, Cys2Tyr3Orn5Pen7-amide.
M S Fanselow, D J Calcagnetti and F J Helmstetter

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 825-830;
You have access
Antagonism of platelet activating factor receptor binding and stimulated phosphoinositide-specific phospholipase C in rabbit platelets.
W J Morrison and S D Shukla

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 831-835;
You have access
Effect of the fatty acid oxidation inhibitor methyl palmoxirate (methyl 2-tetradecylglycidate) on recovery from insulin-induced hypoglycemia in diabetic dogs.
R W Tuman, C R Bowden, M Inman, N Altszuler and G F Tutwiler

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 836-841;
You have access
The nonoxime bispyridinium compound SAD-128 alters the kinetic properties of the nicotinic acetylcholine receptor ion channel: a possible mechanism for antidotal effects.
M Alkondon and E X Albuquerque

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 842-852;
You have access
Prejunctional inhibitory effect of a dopamine D-2 agonist, N-0437, on vascular adrenergic responses.
D J Friedman, D Budai, D N Krause and S P Duckles

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 853-859;
You have access
Differential association of T-2 and T-2 tetraol with mammalian cells.
J L Middlebrook and D L Leatherman

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 860-866;
You have access
Nonpeptide angiotensin II receptor antagonists. III. Structure-function studies.
A T Chiu, J V Duncia, D E McCall, P C Wong, W A Price, M J Thoolen, D J Carini, A L Johnson and P B Timmermans

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 867-874;
You have access
Ethanol and inositol 1,4,5-trisphosphate release calcium from separate stores of brain microsomes.
L C Daniell and R A Harris

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 875-881;
You have access
Blockade of epidermal growth factor-induced uterine contractions by indomethacin or nordihydroguaritic acid.
R M Gardner and G M Stancel

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 882-886;
You have access
Combination of the thromboxane receptor antagonist, sulotroban (BM 13.177; SK&F 95587), with streptokinase: demonstration of thrombolytic synergy.
G A Kopia, L J Kopaciewicz, E H Ohlstein, S Horohonich, B L Storer and R J Shebuski

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 887-895;
You have access
Mechanism of cyclosporine A-induced renal vasoconstriction in the rat.
N F Rossi, P C Churchill, F D McDonald and V R Ellis

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 896-901;
You have access
Alcohol effects on luteinizing hormone releasing hormone-stimulated anterior pituitary and gonadal hormones in women.
J H Mendelson, N K Mello, S K Teoh and J Ellingboe

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 902-909;
You have access
Effect of phthalate acid esters on transport in toad bladder membrane.
S Sabatini, A Fracasso, G Bazzato and N A Kurtzman

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 910-914;
You have access
Assessment of the role of A1/A2 adenosine receptors mediating the purine antinociception, motor and autonomic function in the rat spinal cord.
M Sosnowski, C W Stevens and T L Yaksh

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 915-922;
You have access
Human erythroleukemia cells express functional thromboxane A2/prostaglandin H2 receptors.
P R Mayeux, D E Mais, C Carr and P V Halushka

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 923-927;
You have access
Pharmacological characterization of supersensitivity to naltrexone in squirrel monkeys.
C P France and W H Morse

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 928-936;
You have access
Discriminative stimulus effects of naltrexone in morphine-treated rhesus monkeys.
C P France and J H Woods

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 937-943;
You have access
Pharmacologic discrimination between receptor heterogeneity and allosteric interaction: resultant analysis of gallamine and pirenzepine antagonism of muscarinic responses in rat trachea.
T Kenakin and C Boselli

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 944-952;
You have access
Is L-glutamate a neurotransmitter of baroreceptor information in the nucleus of the tractus solitarius?
C Leone and F J Gordon

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 953-962;
You have access
Pharmacokinetics and pharmacodynamics of prednisolone in obese rats.
A I Nichols, R D'Ambrosio, N A Pyszczynski and W J Jusko

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 963-970;
You have access
Comparison of contractions to serotonin, carbamylcholine and prostaglandin F2 alpha in rat stomach fundus.
R J Secrest, D D Schoepp and M L Cohen

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 971-978;
You have access
Transport of imipenem, a novel carbapenem antibiotic, in the rat central nervous system.
H Suzuki, Y Sawada, Y Sugiyama, T Iga, M Hanano and R Spector

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 979-984;
You have access
Are changes in neuronal calcium channels involved in ethanol tolerance?
S J Dolin and H J Little

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 985-991;
You have access
Diuretic effect of bremazocine, a kappa-opioid with central and peripheral sites of action.
S P Salas, J Roblero, H Ureta and J P Huidobro-Toro

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 992-999;
You have access
Stereospecificity of the discriminative stimulus functions of the dimethylheptyl homologs of 11-hydroxy-delta 8-tetrahydrocannabinol in rats and pigeons.
T U Järbe, A J Hiltunen and R Mechoulam

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1000-1005;
You have access
Central and peripheral opioid modulation of gastric relaxation induced by feeding in dogs.
M Gué, J L Junien and L Bueno

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1006-1010;
You have access
Similarities between the effects of pinacidil and diazoxide on ionic and secretory events in rat pancreatic islets.
P Lebrun, V Devreux, M Hermann and A Herchuelz

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1011-1018;
You have access
The phencyclidine (PCP) analog N-[1-(2-benzo(B)thiophenyl) cyclohexyl]piperidine shares cocaine-like but not other characteristic behavioral effects with PCP, ketamine and MK-801.
W Koek, F C Colpaert, J H Woods and J M Kamenka

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1019-1027;
You have access
Efficacy of erythromycin acistrate (2'-acetyl erythromycin stearate) and erythromycin stearate in experimental infections in mice.
P T Männistö, H Hanhijärvi, A Havas, A Vuorela, H Komulainen and V Rauramaa

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1028-1033;
You have access
Suicide inactivation of cytochrome P-450 by methoxsalen. Evidence for the covalent binding of a reactive intermediate to the protein moiety.
G Labbe, V Descatoire, P Beaune, P Letteron, D Larrey and D Pessayre

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1034-1042;
You have access
Oxygen dependence of omeprazole clearance and sulfone and sulfide metabolite formation in the isolated perfused rat liver.
P W Angus, G W Mihaly, D J Morgan and R A Smallwood

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1043-1047;
You have access
Models of hepatic elimination: implications from studies of the simultaneous elimination of taurocholate and diazepam by isolated rat liver under varying conditions of binding.
M S Ching, D J Morgan and R A Smallwood

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1048-1054;
You have access
Possible involvement of 5-lipoxygenase products in the generation of endothelium-derived relaxing factor.
Y Minami and N Toda

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1055-1060;
You have access
Obesity modifies the adrenergic status of dog adipose tissue.
M Taosis, P Valet, L Estan, M Lafontan, P Montastruc and M Berlan

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1061-1066;
You have access
Valproic acid in amygdala-kindled rats: alterations in anticonvulsant efficacy, adverse effects and drug and metabolite levels in various brain regions during chronic treatment.
W Löscher, J E Fisher, H Nau and D Hönack

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1067-1078;
You have access
Inhibitory actions of a novel benzothiazepine derivative, TA3090, on the electrical and mechanical responses of the rabbit mesenteric artery.
E Nishiye, K Nakao, K Kitamura and H Kuriyama

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1079-1086;
You have access
Effects of opioid agonists on sympathetic and parasympathetic transmission to the dog heart.
T Musha, E Satoh, H Koyanagawa, T Kimura and S Satoh

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1087-1091;
You have access
Inhibition of vagal transmission by cardiac sympathetic nerve stimulation in the dog: possible involvement of opioid receptor.
H Koyanagawa, T Musha, A Kanda, T Kimura and S Satoh

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1092-1096;
You have access
Role of lipoxygenase, cyclooxygenase and cytochrome P-450 metabolites in contractions of isolated guinea pig pulmonary venules induced by hypoxia and anoxia.
W R Tracey, J R Bend, J T Hamilton and N A Paterson

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1097-1104;
You have access
Cyclosporine treatment of normal rats produces a rise in blood pressure and decreased renal vascular responses to nerve stimulation, vasoconstrictors and endothelium-dependent dilators.
J F Gerkens

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1105-1112;
You have access
Liposome-mediated delivery of gadolinium-diethylenetriaminopentaacetic acid to hepatic cells: a P-31 NMR study.
J Vion-Dury, S Masson, J M Devoisselle, M Sciaky, F Desmoulin, S Confort-Gouny, D Coustaut and P J Cozzone

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1113-1118;
You have access
Relation between density (maximum binding) of alpha adrenoceptor binding sites and contractile response in four canine vascular tissues.
A G Shi, C Y Kwan and E E Daniel

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1119-1124;
You have access
Effects of endothelin on regional blood flows in squirrel monkeys.
M Clozel and J P Clozel

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1125-1131;
You have access
Antioxidants protect against glutamate-induced cytotoxicity in a neuronal cell line.
M Miyamoto, T H Murphy, R L Schnaar and J T Coyle

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1132-1140;
You have access
Alpha-1 adrenergic stimulation of 1,4,5-inositol trisphosphate formation in ventricular myocytes.
S F Steinberg, L M Kaplan, T Inouye, J F Zhang and R B Robinson

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1141-1148;
You have access
Solubilization and characterization of the liver peripheral-type benzodiazepine receptor.
A L Parola, C W Putnam, D H Russell and H E Laird

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1149-1155;
You have access
D1 dopamine agonist effects assessed in vivo with [14C]-2-deoxyglucose autoradiography.
J M Trugman, W S Arnold, N Touchet and G F Wooten

Journal of Pharmacology and Experimental Therapeutics September 1989, 250 (3) 1156-1160;

Main menu

User menu

Search

Table of Contents

In this issue

Navigate

More Information

ASPET's Other Journals